Author:
Mariniello B.,Finco I.,Sartorato P.,Patalano A.,Iacobone M.,Guzzardo V.,Fassina A.,Mantero F.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference31 articles.
1. Allolio B, Hahner S, Weismann D, Fassnacht M. Management of adrenocortical carcinoma. Clin Endocrinol 2004, 60: 273–87.
2. Reincke M. Mutations in adrenocortical tumors. Horm Metab Res 1998, 30: 447–55.
3. Kirschner LS. Signaling pathways in adrenocortical cancer. Ann N Y Acad Sci 2002, 968: 222–39.
4. Terzolo M, Pia A, Berruti A, et al. Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer. J Clin Endocrinol Metab 2000, 85: 2234–8.
5. Terzolo M, Angeli A, Fassnacht M, et al. Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med 2007, 356: 2372–80.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献